EcoDrugPlus

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSMMNG00015012975
Gene Symbol: GUCY1B1
3 Cross references
209 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSMMNG00015013415
Gene Symbol: HSP90AA1
3 Cross references
204 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSMMNG00015020245
Gene Symbol: HMGB1
3 Cross references
226 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSMMNG00015011469
Gene Symbol: HRH1
3 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSMMNG00015008125
Gene Symbol: HRH2
3 Cross references
249 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSMMNG00015003462
Gene Symbol: HRH3
3 Cross references
117 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSMMNG00015001127
Gene Symbol: HRH4
1 Cross references
103 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSMMNG00015010635
Gene Symbol: HDAC1
3 Cross references
278 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSMMNG00015015836
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSMMNG00015012961
Gene Symbol: HDAC11
3 Cross references
197 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSMMNG00015005256
Gene Symbol: HDAC2
2 Cross references
199 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSMMNG00015002599
Gene Symbol: HDAC3
3 Cross references
156 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).